We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pharmacological Treatment of Apathy in Neurodegenerative Diseases: A Systematic Review.
- Authors
Drijgers, Rosa L.; Aalten, Pauline; Winogrodzka, Ania; Verhey, Frans R. J.; Leentjens, Albert F. G.
- Abstract
Objective: To evaluate the efficacy of pharmacological treatment of apathy in patients with neurodegenerative diseases. Methods: Systematic review of studies assessing the effects of pharmacological treatment on apathy in neurodegenerative diseases. Results: Thirty-five studies were included: 2 meta-analyses, 13 randomized controlled trials (RCTs), 14 open-label studies, 5 case series, and 1 single case study. Eight studies included apathy as a primary outcome. A cholinesterase inhibitor was investigated in 24 studies, methylphenidate in 5, and other medications in 6 studies. Most RCTs of cholinesterase inhibitors reported a small but statistically significant improvement of apathetic symptoms. Conclusions: Although some medications are promising candidates for further study, there is as yet insufficient evidence that pharmacological treatment improves apathetic symptoms in patients with neurodegenerative disease. Large-scale, placebo-controlled RCTs with apathy as a primary outcome measure are needed to establish the potential benefit of pharmacological treatment of apathy. Copyright © 2009 S. Karger AG, Basel
- Subjects
TREATMENT of neurodegeneration; ALZHEIMER'S patients; PARKINSON'S disease; SYMPTOMATIC Parkinson's disease; DEMENTIA; APATHY; STATISTICS; PHARMACOLOGY
- Publication
Dementia & Geriatric Cognitive Disorders, 2009, Vol 28, Issue 1, p13
- ISSN
1420-8008
- Publication type
Article
- DOI
10.1159/000228840